Author

Francisco Puerta-Martinez

Albert Einstein College of Medicine

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:mouse· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Assay:imaging· 1

Frequent Co-Authors

A. S. Daba· 1 shared Anzar MujeebiD· 1 shared Apoorva Mirji· 1 shared Ben Z. StangeriD· 1 shared Brandon L. McClellaniD· 1 shared Chaim T. SneidermaniD· 1 shared Christian Adkisson· 1 shared Christopher L. MoerteliD· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. S. Daba

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

TMEM Doorway Mediated Metastasis in Pancreatic Ductal Adenocarcinoma by Tie2 Signaling

Érika Pereira Zambalde, Lina A. Ariyan, Francisco Puerta-Martinez, Yu Quin Zhu, Priyanka Patil, Nicole C. Panarelli, Jiufeng Li, Yookyung Jung, Christian Adkisson, Jakeb S. S. M. Petersen, Dianne Cox, Hava Gil-Henn, Robert J. Eddy, Ben Z. Stanger, David R. Entenberg, , John C. McAuliffe

This study identifies TMEM doorways as a mechanism for metastasis in PDAC, showing Tie2 macrophages facilitate intravasation and that targeting Tie2 improves survival in mouse models.

bioRxiv · Dec 9, 2025 · PreprintCancer Biology

CD200 depletion in glioma enhances antitumor immunity and induces tumor rejection

Itay Raphael, Anzar Mujeeb, Elisabet Ampudia-Mesias, ReidAnn E. Sever, Brandon L. McClellan, Stephen C. Frederico, Chaim T. Sneiderman, Apoorva Mirji, A. S. Daba, Francisco Puerta-Martinez, Michal Nisnboym, Wilson Barry Edwards, Michael W. Graner, Christopher L. Moertel, Maria Graciela Castro, , Michael R. Olin

This study shows that CD200 depletion in gliomas enhances antitumor immunity and leads to tumor rejection by modulating immune cell activity and cytokine expression.

bioRxiv · Sep 8, 2024 · PreprintImmunology